Literature DB >> 24220018

Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae.

Wei D Li1, Cui P Yan1, Y Wu1, Ze B Weng1, Fang Z Yin2, Guang M Yang2, Bao C Cai3, Zhi P Chen4.   

Abstract

Osteoporosis is a disease of bones that leads to an increased risk of fracture. Fructus of Psoralea corylifolia L. (scurfpea fruit) is commonly utilized for treating bone fractures and joint diseases for thousands of years in China. This study was aimed to screen active principles, which might have the potency to stimulate osteoblasts proliferation and differentiation from scurfpea fruit. A HPLC method was established to analyze the main components in scurfpea fruit. Totally 11 compounds have been identified by comparing their retention time with correspondent standard substances. The MTT and ALP methods were utilized for the assay of osteoblasts proliferation and differentiation activity. Icariin, a prenylated flavonoid glycoside was treated as the positive control. Bavachin and isobavachin significantly stimulated cell proliferation, while bakuchiol exhibited stronger effect to enhance osteoblasts differentiation. All these compounds were found with a characterized structure that in each of their molecule backbones, a prenylated side chain was attached. These results lead to a hypothesis that prenyl group might be crucial to exhibit the activity. The structure-effect relationship of these compounds with prenyl group in mouse primary calvarial osteoblasts needs to be explored in further research.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Differentiation; Osteoporosis; Proliferation; Psoralea corylifolia L.

Mesh:

Substances:

Year:  2013        PMID: 24220018     DOI: 10.1016/j.phymed.2013.09.015

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  28 in total

Review 1.  Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.

Authors:  Yue Zhuo; Meng Li; Qiyao Jiang; Hanzhong Ke; Qingchun Liang; Ling-Feng Zeng; Jiansong Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

Review 2.  Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.

Authors:  Junjie Lu; Desheng Hu; Chen Ma; Bo Shuai
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

3.  Synthesis of Psoralidin derivatives and their anticancer activity: First synthesis of Lespeflorin I1.

Authors:  Pallab Pahari; Ujwal Pratim Saikia; Trinath Prasad Das; Chendil Damodaran; Jurgen Rohr
Journal:  Tetrahedron       Date:  2016-06-09       Impact factor: 2.457

4.  Metabolic profiling of corylin in vivo and in vitro.

Authors:  Zifei Qin; Shishi Li; Zhihong Yao; Xiaodan Hong; Jinjin Xu; Pei Lin; Guoping Zhao; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Biomed Anal       Date:  2018-03-26       Impact factor: 3.935

5.  Psoralen stimulates osteoblast proliferation through the activation of nuclear factor-κB-mitogen-activated protein kinase signaling.

Authors:  Feimeng Li; Qihuo Li; Xiaoqing Huang; Yunting Wang; Chana Ge; Yong Qi; Wei Guo; Hongtao Sun
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

6.  Psoralen and Isopsoralen Ameliorate Sex Hormone Deficiency-Induced Osteoporosis in Female and Male Mice.

Authors:  Xiaomei Yuan; Yanan Bi; Zeman Yan; Weiling Pu; Yuhong Li; Kun Zhou
Journal:  Biomed Res Int       Date:  2016-04-30       Impact factor: 3.411

7.  The Extract of Fructus Psoraleae Promotes Viability and Cartilaginous Formation of Rat Chondrocytes In Vitro.

Authors:  Xin Pan; Kang Xu; Xuefeng Qiu; Wen Zhao; Dong Wang; Li Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-23       Impact factor: 2.629

8.  The Evaluation of Toxicity Induced by Psoraleae Fructus in Rats Using Untargeted Metabonomic Method Based on UPLC-Q-TOF/MS.

Authors:  Yanyan Xu; Yiwei Zhao; Jiabin Xie; Xue Sheng; Yubo Li; Yanjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-27       Impact factor: 2.629

9.  Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.

Authors:  Han Xing; Jing Yang; Kaidi Ren; Zifei Qin; Peile Wang; Xiaojian Zhang; Zhihong Yao; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Pharmacol       Date:  2020-08-04       Impact factor: 4.810

10.  Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.

Authors:  Yang Li; Chunxia Xu; Jinjin Xu; Zifei Qin; Shishi Li; Liufang Hu; Zhihong Yao; Frank J Gonzalez; Xinsheng Yao
Journal:  J Pharm Pharmacol       Date:  2020-07-09       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.